Novartis (NOVN SW) CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'

The Novartis CEO's warning regarding the implications of Trump's drug pricing policy suggests potential shifts in the pharmaceutical landscape, particularly affecting pricing strategies and profitability within the U.S.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

UK Grocery Inflation (Apr): 3.8% (prev. 4.3%), Worldpanel

Majestic Labs AI has developed new AI servers intended to address memory constraints in running large models, WSJ reports

Novartis (NOVN SW) CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'

Barclays (BARC LN) had GBP 15bln in exposure to private credit funds at the end of Q1

Israeli army warns residents of 16 villages in southern Lebanon to evacuate towards Sidon

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

market. This could lead to market volatility, especially in equities related to the pharmaceuticals sector, as investors adjust their expectations on earnings and growth. The broader geopolitical context could also influence currency markets, particularly for the USD and EUR, as policies affect trade and investment flows.

Related headlines

The whole workspace, free to try.

Try it free